chlorzoxazone
Ligand Summary
A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
UNII: H0DE420U8G
PubChem: 2733
Guide to Pharmacology: 2322
ChEMBL: CHEMBL1371
DrugCentral: 626
LyCHI: 3TU93933C3XR
Target Activities
KCNN4
Intermediate conductance calcium-activated potassium channel protein 4
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
EC50 | 4 | |||||
CYP1A2
Cytochrome P450 1A2
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
AC50 | 6.4 | None, None:None:None | ||||
KCNMA1
Calcium-activated potassium channel subunit alpha-1
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
EC50 | 4.52 | OPENER | ||||